Welcome to KAT Innovation

Our team works hard for you...
One STim At A Time!

Osteoporosis

Osteoporosis is a disease more common than stroke, heart attack and breast cancer combined. Combined with severe chronic kidney disease, it is a disease that is difficult to treat medically.
Our solution

Our technology consists of applying a low-intensity electrical current that stimulates bone formation through electrodes for patients with osteoporosis driven or not by severe chronic kidney disease addressing an unmet medical need.
The company

Our team is composed of experts, scientific collaborators and international partners.

KAT Innovation strives to contribute to health innovation by developing and commercializing emerging technologies that address unmet medical needs, for people on Earth, for astronauts during long space stays, while also extending its benefits to remote populations through telemedicine and Artificial Intelligence.

Osteoporosis and CKD

Osteoporosis is a silent disease that gradually reduces bone density and quality. Over the years, bones become progressively weaker.

Osteoporosis is sometimes caused by severe chronic kidney disease (CKD). Due to this irreversible disease, the kidney's blood filtration function is affected, leading to additional health problems.

A solution

Our OSTAAT™ medical device stimulates bone growth in patients with osteoporosis associated or not with severe chronic kidney disease who are looking for a non-invasive solution to prevent or cure any type of fracture* and, more specifically, hip fracture.

* Claims will be addressed in future clinical trials.

Scientific evidence

Phase 1 and 2 In Vitro studies conducted at the Université du Québec à Montréal (UQAM) since August 2022 have made it possible to answer the hypotheses raised by our researchers on the link between electrical stimulation with specific parameters and bone formation. The results will be published shortly.

Medication

Medication is not recommended for patients with osteoporosis associated with severe chronic kidney disease (CKD) due to impaired kidney function, leaving them with limited or no viable treatment options.

For patients with primary osteoporosis, medication may be an option, but they must contend with a significant risk of experiencing side effects.

The technology

OSTAAT™ involves applying a specific electric current through electrodes on the skin, intervening in the complex mechanisms of cell membranes allowing calcium to enter cells promoting bone growth.

An international network

KAT Innovation is supported by incubators and accelerators in Canada, France, USA, UK, Taiwan, and Spain.

Medical partners from five university hospitals in France, Canada, Spain, and Tunisia work in collaboration with KAT Innovation.